NCT06016842
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis treatment 3 recruiting NCT06604923
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment. No drug interventions Not Available Not Available active_not_recruiting NCT06591455
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis treatment 0 not_yet_recruiting NCT06591468
A Multicenter, Randomized, Controlled Trial of Prednisone Combined with Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis with Moderate to Severe Interface Hepatitis Characteristics treatment 2 / 3 not_yet_recruiting NCT05896124
CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) treatment 2 recruiting NCT04047160
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) treatment 1 completed NCT03521297
Probiotics in PBC Patients of Poor Response to UDCA treatment 2 unknown_status NCT03188146
Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid Not Available Not Available recruiting NCT03124108
Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid treatment 2 completed NCT00145964
Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC) No drug interventions Not Available Not Available unknown_status NCT02360852
IBAT Inhibitor A4250 for Cholestatic Pruritus treatment 2 terminated NCT02932449
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis No drug interventions Not Available Not Available active_not_recruiting NCT00242125
Family Studies in Primary Biliary Cirrhosis (PBC) No drug interventions Not Available Not Available unknown_status NCT04526665
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) treatment 3 active_not_recruiting NCT02916290
Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis treatment 3 unknown_status NCT00844402
Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis treatment 3 completed NCT00588302
Moexipril for Primary Biliary Cirrhosis treatment 2 completed NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity No drug interventions Not Available Not Available completed NCT02823353
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis treatment 3 completed NCT01161953
Genetic Epidemiology of Primary Biliary Cirrhosis (PBC) No drug interventions Not Available Not Available active_not_recruiting NCT00805805
Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis treatment 3 completed NCT02965911
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA treatment 1 / 2 withdrawn NCT04893993
PBC Induced Fatigue Treated With Thiamine treatment 4 unknown_status NCT03445585
Biobank for Cholestatic Liver Diseases. No drug interventions Not Available Not Available recruiting NCT00393185
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis No drug interventions treatment 1 withdrawn NCT04604652
Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis No drug interventions treatment 2 completed NCT00575042
Use of Fenofibrate for Primary Biliary Cirrhosis treatment 2 completed NCT01603199
High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis No drug interventions supportive_care Not Available completed NCT02931513
sCD163 in PBC Patients - Assessment of Treatment Response No drug interventions Not Available Not Available recruiting NCT00587119
Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis treatment Not Available withdrawn NCT00364819
Initial Study of Rituximab to Treat Primary Biliary Cirrhosis treatment 1 / 2 completed NCT02916641
Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid treatment 3 unknown_status NCT02659696
Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis No drug interventions Not Available Not Available completed NCT02376335
B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis treatment 2 completed NCT03590886
Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response No drug interventions Not Available Not Available completed NCT00746486
Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC) treatment 3 terminated NCT02823366
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid treatment 3 unknown_status NCT04514965
Bezafibrate in Patients With Primary Biliary Cholangitis (PBC) No drug interventions Not Available Not Available recruiting NCT03337074
Paternally Inherited Phenotypes in Cholestasis No drug interventions Not Available Not Available unknown_status NCT00490620
Study of Combivir for Patients With Primary Biliary Cirrhosis treatment 2 / 3 completed NCT01389973
A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid treatment 2 completed NCT01662973
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis No drug interventions treatment 1 / 2 unknown_status NCT04791527
Online Wellness Intervention for Primary Biliary Cholangitis (PBC) No drug interventions treatment Not Available completed NCT00943176
Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC) treatment 1 completed NCT02193360
Pilot Study of FFP104 Dose Escalation in PBC Subjects No drug interventions treatment 1 / 2 unknown_status NCT01510860
Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis treatment 4 completed NCT02557360
Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis No drug interventions treatment 4 completed NCT01249092
Pentoxifylline for Primary Biliary Cirrhosis treatment 2 completed NCT04933292
A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome treatment 4 unknown_status NCT03226067
Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. treatment 2 completed NCT02924701
sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis No drug interventions Not Available Not Available active_not_recruiting NCT03743272
Repeatability and Reproducibility of Multiparametric MRI No drug interventions Not Available Not Available unknown_status NCT04522869
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia No drug interventions treatment 1 / 2 completed NCT03112681
Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis treatment 2 completed NCT02955602
Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) treatment 2 completed NCT01857284
Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis treatment 3 completed NCT02963077
A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 treatment 1 completed NCT03668145
Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis No drug interventions treatment Not Available unknown_status NCT01614405
Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis treatment Not Available completed NCT04956328
Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC) treatment 3 unknown_status NCT04751188
A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis treatment 3 unknown_status NCT01440309
Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis treatment 1 unknown_status NCT03082937
An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects treatment 1 completed NCT05374200
Mind-body Wellness Intervention in Primary Biliary Cholangitis (PBC) No drug interventions treatment Not Available completed NCT03809559
Repeatability and Reproducibility of Quantitative MRCP No drug interventions Not Available Not Available completed NCT03301506
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) treatment 3 recruiting NCT02321306
An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis treatment 2 withdrawn NCT02135536
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis treatment 2 completed NCT03665519
Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis treatment Not Available completed NCT06061341
TruGraf Liver Gene Expression Serial Test No drug interventions Not Available Not Available enrolling_by_invitation NCT01473524
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis treatment 3 completed NCT01141296
Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis treatment 2 withdrawn NCT02846896
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland No drug interventions Not Available Not Available completed NCT01904058
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis treatment 2 completed NCT01879735
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT basic_science 1 completed NCT04278820
A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) No drug interventions treatment 2 unknown_status NCT02078882
Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis treatment 4 completed NCT03253276
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT basic_science 0 completed NCT06519162
Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome No drug interventions Not Available Not Available recruiting NCT02477462
Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients No drug interventions Not Available Not Available completed NCT01430429
Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody No drug interventions Not Available 2 terminated NCT03489889
Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine treatment Not Available completed NCT02026401
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis treatment 2 completed NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford No drug interventions Not Available Not Available recruiting NCT01865812
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis basic_science 2 completed NCT02937012
Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders treatment 3 unknown_status NCT02609048
Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC) treatment 2 terminated NCT05050136
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis treatment 2 recruiting NCT01654731
Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis treatment 3 completed NCT04076527
Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis Not Available Not Available recruiting NCT06051617
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis No drug interventions treatment 3 recruiting NCT06525311
A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. treatment 1 recruiting NCT06060665
IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) treatment 3 recruiting NCT06383403
A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. treatment 3 recruiting NCT06488911
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate No drug interventions treatment 3 enrolling_by_invitation NCT05190523
Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis No drug interventions treatment 2 completed NCT06365424
Fenofibrate in Patients with Primary Biliary Cholangitis (PBC) treatment 2 / 3 recruiting NCT06447168
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment No drug interventions Not Available Not Available recruiting NCT04650243
Clinical Research of UCDA Reducing Medication Regimen in Stable PBC treatment 4 recruiting NCT04950764
An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) treatment 1 recruiting NCT06174402
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis treatment 2 / 3 recruiting NCT05450887
Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis treatment 3 completed NCT04620733
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA) treatment 3 completed NCT05104853
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis No drug interventions treatment 1 / 2 active_not_recruiting NCT02943447
Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis treatment 2 terminated NCT02516605
A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients treatment 2 completed NCT04376528
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy treatment 4 unknown_status NCT04618575
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1 treatment 4 unknown_status NCT05133336
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis treatment 2 / 3 active_not_recruiting NCT06371196
Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule No drug interventions treatment 4 not_yet_recruiting NCT05749822
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis treatment 2 / 3 recruiting NCT05786482
Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions No drug interventions treatment Not Available active_not_recruiting NCT03742973
A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA treatment 2 terminated NCT06098027
Study of [14C]CS0159 in China Healthy Subjects other 1 completed NCT03703076
A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life No drug interventions Not Available Not Available unknown_status NCT06309589
The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis treatment Not Available completed NCT05292872
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients Not Available Not Available completed NCT03545672
Early Identification of Myocardial Impairment in PBC No drug interventions Not Available Not Available completed NCT05014672
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness treatment 2 completed NCT06427395
Open-Label Extension Study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis treatment 3 recruiting NCT03322943
The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital No drug interventions Not Available Not Available completed NCT03684187
Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis No drug interventions treatment Not Available suspended NCT05919433
Detection Program for Patients With Primary Biliary Cholangitis Lost in the System No drug interventions Not Available Not Available recruiting NCT06417398
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases No drug interventions treatment 0 not_yet_recruiting NCT04617561
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II treatment 4 unknown_status NCT05151809
National Database on Primary Biliary Cholangitis No drug interventions Not Available Not Available recruiting NCT03155932
Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis treatment 2 terminated NCT03394924
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis No drug interventions treatment 2 completed NCT06247735
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants with Primary Biliary Cholangitis (PBC) with Inadequate Response to Ursodeoxycholic Acid (UDCA) And/or Obeticholic Acid (OCA) Treatment. treatment 2 recruiting NCT04265235
EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study No drug interventions treatment Not Available terminated NCT02701166
The Effect of Bezafibrate on Cholestatic Itch treatment 3 unknown_status NCT03092765
Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid No drug interventions treatment 2 terminated NCT03954327
Combination Antiretroviral Therapy (cART) for PBC treatment 2 completed NCT03602560
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) treatment 3 completed NCT05624294
Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects treatment 1 completed NCT04594694
Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC treatment 2 active_not_recruiting NCT03345589
A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis No drug interventions treatment 4 unknown_status NCT05751967
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis prevention 3 recruiting NCT05239468
Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC treatment 2 active_not_recruiting NCT05293938
A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients Not Available Not Available withdrawn